{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-047590","form_type":"8-K","ticker":"PRME","cik":"0001894562","company_name":"Prime Medicine, Inc.","filed_at":"2026-07-08T12:02:02+00:00","discovered_at":"2026-07-08T12:05:00.259038+00:00","generated_at":"2026-07-08T12:05:10.332891+00:00","sec_items":["8.01"],"event_type":"litigation","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Prime Medicine wins arbitration against Beam; PM647 for AATD confirmed within Prime's field","bullets":["Arbitration tribunal ruled PM647 (AATD candidate) is within Prime's 'Field' under 2019 Collaboration Agreement with Beam.","Tribunal denied Beam's claims for damages and injunctive relief; Prime did not breach agreement.","Remaining claims from both parties were denied.","This removes legal overhang on Prime's AATD program."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-047590","json":"https://secwatch.observer/filing/0001628280-26-047590.json","markdown":"https://secwatch.observer/filing/0001628280-26-047590.md","text":"https://secwatch.observer/filing/0001628280-26-047590.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1894562/000162828026047590/0001628280-26-047590-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1894562/000162828026047590/prme-20260706.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-08T12:05:10.332891+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}